Brightwell J J, Taylor B K
Department of Pharmacology, School of Medicine, Tulane University, New Orleans, LA 70112, USA.
Neuroscience. 2009 Apr 21;160(1):174-85. doi: 10.1016/j.neuroscience.2009.02.023. Epub 2009 Feb 14.
Current theories of neuropathic hypersensitivity include an imbalance of supraspinal inhibition and facilitation. Our overall hypothesis is that the locus coeruleus (LC), classically interpreted as a source of pain inhibition, may paradoxically result in facilitation after tibial and common peroneal nerve transection (spared sural nerve injury--SNI). We first tested the hypothesis that non-noxious tactile hind paw stimulation of the spared sural innervation territory increases neuronal activity in the LC in male rats. We observed a bilateral increase in the stimulus-evoked expression of transcription factors Fos and phosphorylated CREB (pCREB) in LC after SNI but not sham surgery; these markers of neuronal activity correlated with the intensity of tactile allodynia. We next tested the hypothesis that noradrenergic neurons contribute to the development of neuropathic pain. To selectively destroy these neurons, we delivered antidopamine-beta-hydroxylase saporin (anti-DbetaH-saporin) into the i.c.v. space 2 weeks before SNI. We found that anti-DbetaH-saporin, but not an IgG-saporin control, reduced behavioral signs of tactile allodynia, mechanical hyperalgesia, and cold allodynia from 3 to 28 days. after SNI. Our final experiment tested the hypothesis that the LC contributes to the maintenance of neuropathic pain. We performed SNI, waited 2 weeks for maximal allodynia and hyperalgesia to develop, and then administered the local anesthetic lidocaine (4%) directly into the LC parenchyma. Lidocaine reduced all behavioral signs of neuropathic pain in a reversible manner, suggesting that the LC contributes to pain facilitation. We conclude that, in addition to its well-known inhibition of acute and inflammatory pain, the LC facilitates the development and maintenance of neuropathic pain in the SNI model. Further studies are needed to determine the facilitatory pathways emanating from the LC.
目前关于神经性超敏反应的理论包括脊髓上抑制和易化的失衡。我们的总体假设是,蓝斑(LC)传统上被认为是疼痛抑制的来源,但在胫神经和腓总神经横断(保留腓肠神经损伤——SNI)后可能会反常地导致易化。我们首先测试了这样一个假设:对保留的腓肠神经支配区域进行非伤害性后爪触觉刺激会增加雄性大鼠蓝斑中的神经元活动。我们观察到,在SNI后而非假手术后,蓝斑中刺激诱发的转录因子Fos和磷酸化CREB(pCREB)的表达出现双侧增加;这些神经元活动标记物与触觉异常性疼痛的强度相关。接下来,我们测试了去甲肾上腺素能神经元促成神经性疼痛发展的假设。为了选择性地破坏这些神经元,我们在SNI前2周将抗多巴胺-β-羟化酶皂草素(抗DβH-皂草素)注入脑室内。我们发现,抗DβH-皂草素而非IgG-皂草素对照在SNI后3至28天减轻了触觉异常性疼痛、机械性痛觉过敏和冷异常性疼痛的行为体征。我们的最后一项实验测试了蓝斑促成神经性疼痛维持的假设。我们进行了SNI,等待2周以使最大程度的异常性疼痛和痛觉过敏发展,然后将局部麻醉剂利多卡因(4%)直接注入蓝斑实质。利多卡因以可逆方式减轻了神经性疼痛的所有行为体征,表明蓝斑促成了疼痛易化。我们得出结论,除了其对急性和炎性疼痛的众所周知的抑制作用外,蓝斑在SNI模型中还促成神经性疼痛的发展和维持。需要进一步研究以确定源自蓝斑的易化途径。